Search Results 1221-1230 of 17821 for monoclonal antibody

1. A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache - Mayo Clinic

   Current use or any prior exposure to any calcitonin-gene-related peptide (CGRP) antibody ... Known hypersensitivity to multiple drugs, monoclonal antibodies or ...

2. Clinical trials - Oncology (Medical)

   The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

3. Haemophilus b conjugate vaccine (intramuscular route) - Side effects & uses - Mayo Clinic

   The vaccine works by causing your body to produce its own protection (antibodies) against the disease. Haemophilus b conjugate vaccine is prepared by adding ...

4. Study Of Alirocumab (REGN727/SAR236553) In Patients With Heterozygous Familial Hypercholesterolemia (HeFH) Undergoing Low-density Lipoprotein (LDL) Apheresis Therapy - Mayo Clinic

   Patients who have been treated with at least 1 dose of alirocumab or any other anti-PCSK9 monoclonal antibody in any other clinical studies; Pregnant or ...

5. A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments - Mayo Clinic

   ... antibody, 1 immunomodulatory imide drug (IMiD) ... monoclonal protein, and skin changes) 2 ... antibody-drug conjugates are not excluded) 6. History ...

6. High blood protein When to see a doctor - Mayo Clinic

   https://www.niddk.nih.gov/health-information/kidney-disease/amyloidosis. Accessed Sept. 16, 2024. Monoclonal gammopathy of undetermined significance (MGUS).

7. Evaluation of CRS-207 With Pembrolizumab in Previously Treated MPM - Mayo Clinic

   Active secondary malignancy; Prior anti-cancer monoclonal antibody within 4 weeks prior to first dose of study drug, or not recovered from adverse effects ...

8. Brain Metastases Clinical Trials - Mayo Clinic Research

   Sacituzumab govitecan is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug, called govitecan. Sacituzumab is a form of targeted ...

9. Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001) - Mayo Clinic

   Previous severe hypersensitivity reaction to another monoclonal antibody (mAb). Active autoimmune disease or a documented history of autoimmune disease or ...

10. A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy - Mayo Clinic

    History of severe allergic or anaphylactic reactions to monoclonal antibodies or known hypersensitivity to any component of the obinutuzumab infusion; ...